Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00662194




Registration number
NCT00662194
Ethics application status
Date submitted
17/04/2008
Date registered
21/04/2008
Date last updated
10/03/2014

Titles & IDs
Public title
Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Scientific title
A Study of Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C or Hepatitis B
Secondary ID [1] 0 0
ALF-55/08
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
HIV-hepatitis Co-infection 0 0
HIV Infections 0 0
Condition category
Condition code
Infection 0 0 0 0
Studies of infection and infectious agents
Infection 0 0 0 0
Other infectious diseases
Infection 0 0 0 0
Sexually transmitted infections
Oral and Gastrointestinal 0 0 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
1 - HIV-HBV co-infected and receiving anti-retroviral therapy (ART) and CD4 count \> 500cells/mm3

2 - HIV-HBV co-infected and receiving ART and CD4 count 200-500 cells/mm3

3 - HIV-HBV co-infected and receiving ART and CD4 count \<200cells/mm3

4 - HIV-HBV co-infected and not receiving ART

5 - HIV-HCV co-infected \& receiving anti-retroviral therapy (ART) and CD4 count \> 500cells/mm3

6 - HIV-HCV co-infected and receiving ART and CD4 count 200-500 cells/mm3

7 - HIV-HCV co-infected and receiving ART and CD4 count \<200cells/mm3

8 - HIV-HCV co-infected and not receiving ART
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
TLR change with HIV co-infection therapy
Timepoint [1] 0 0
6 months
Secondary outcome [1] 0 0
TLR change patterns on spontaneously and on treatment resolved HBV or HCV in the co-infected setting
Timepoint [1] 0 0
6 months

Eligibility
Key inclusion criteria
* HIV and either HBV or HCV co-infection
* 18 years and older
* able to give informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* HIV-HBV-HCV triple infection

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
UNKNOWN
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/04/2008
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/10/2014
Actual
Sample size
Target
40
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
The Alfred Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
3004 - Melbourne

Funding & Sponsors
Primary sponsor type
Government body
Name
Bayside Health
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Monash Medical Centre
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Government body
Name [2] 0 0
National Institutes of Health (NIH)
Address [2] 0 0
Country [2] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Joe Sasadeusz, MD, PhD
Address 0 0
The Alfred
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Jennifer Audsley, PhD
Address 0 0
Country 0 0
Phone 0 0
+613 99030184
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT00662194